XML 45 R47.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation - Additional Information (Detail)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 05, 2019
shares
Jun. 30, 2020
shares
Mar. 31, 2020
USD ($)
plan
$ / shares
shares
Dec. 31, 2019
shares
Dec. 31, 2017
shares
Jun. 07, 2018
shares
Dec. 07, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of equity compensation plans | plan     3        
Additional awards granted (in shares)     412,417        
2005 Aerie Pharmaceutical Stock Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Additional awards granted (in shares)     0        
2013 Omnibus incentive plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Equity awards (in shares)     10,229,068     4,500,000  
Inducement Award Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Equity awards (in shares)     874,500       418,000
Additional shares authorized 100,000            
Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense | $     $ 67.6        
Weighted-average remaining vesting period     2 years 6 months        
Restricted stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense related to unvested awards | $     $ 21.2        
Weighted-average of remaining vesting period     2 years 7 months 6 days        
Granted (in shares)     82,492        
Vested (in shares)     184,436        
Non-vested shares cancelled and replaced       43,071      
Shares cancelled     18,606        
Granted (in dollars per share) | $ / shares     $ 21.13        
Restricted stock | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based awards, vesting period     1 year        
Restricted stock | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based awards, vesting period     4 years        
Restricted Stock With Non-Market Performance Conditions              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares)         98,817    
Vested (in shares)     69,171        
Restricted Stock With Non-Market Performance Conditions | Forecast              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vested (in shares)   29,646          
Stock Appreciation Rights (SARs)              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares)     12,000        
Shares cancelled     15,619        
Granted (in dollars per share) | $ / shares     $ 18.51        
Non-vested restricted stock units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense related to unvested awards | $     $ 1.4        
Weighted-average of remaining vesting period     2 years 6 months        
Granted (in dollars per share) | $ / shares     $ 19.26        
RSUs outstanding     30,938